STRYKER CORP: Subpoena on Consulting Fees Issue Enforced in Jan.

Stryker Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that a court agreed to enforce in January 2009, a civil subpoena issued by the U.S. Department of Health and Human…

STRYKER CORPORATION: Responding to DOJ’s Document Request

Stryker Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that the Company is in the process of responding to the U.S. Department of Justice regarding subpoenas requesting certain documents.

In 2008,…

STRYKER CORPORATION: Grand Jury Probe on Antitrust Claims Ended

Stryker Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that in 2008, the Company was advised by the U.S. Department of Justice, Antitrust Division, that the Department had closed its…

STRYKER CORP: SEC Probe on Possible FCPA Violations Ongoing

Stryker Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that an informal inquiry over possible violations of the Foreign Corrupt Practices Act in connection with the sale of medical devices…

STRYKER CORP: Cooperating with FDA on Site Compliance Issues

Stryker Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that the Company is cooperating with the U.S. Food and Drugs Administration regarding the quality systems and compliance issues at its…